Respondents included individuals using widely prescribed GLP-1 agents such as Ozempic, Wegovy, Mounjaro, and Zepbound, which are indicated for glycemic control in type 2 diabetes and, in some cases, for chronic weight management
the injections are prescribed and given intramuscularly
Obesity also compromises the effectiveness of radiation therapy by increasing local recurrence rates and treatment-related complications [22]
If you experience any suspected side effects from GLP-1 medications, you can report them through the MHRA Yellow Card scheme, which helps monitor medication safety
Gao Feng, Email: [email protected]
Recent advancements in biotechnology have enabled the development of oral proteins and peptides as innovative treatment options for diabetes